环素D1的过度表达是晚期乳腺癌病例的积极预后因素
Asude Aksoy1, Merve Sevim2, Gokhan Artas3
1Department of Medical Oncology, University of Health Sciences, Fethi Sekin City Hospital Health Applications Research Center, Elazig, Turkiye.
Northern clinics of Istanbul
|February 8, 2024
概括
循环D1 (CDDN1) 在晚期乳腺癌 (BC) 中升高. 在某些晚期BC病例中,高CDDN1表达可能表明更好的预后,这表明其作为预后生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物研究 生物标志物研究
背景情况:
- 环素D1 (CDDN1) 对于细胞周期进展至关重要.
- CDDN1调节循环素依赖的激酶CDK4和CDK6.
- 了解CDDN1在乳腺癌中的作用对于预后至关重要.
研究的目的:
- 研究CDDN1表达与乳腺癌临床病理特征之间的关联.
- 为了确定CDDN1是否可以作为乳腺癌病例的预后生物标志物.
主要方法:
- 在70例乳腺癌 (BC) 病例和10例健康对照中对CDDN1表达的免疫组织化学分析.
- 将CDDN1表达的分类为"低" (L) 和"高" (H) 组.
- 临床病理特征和生存率的统计评估.
主要成果:
- 与正常和有限阶段的BC相比,CDDN1表达在晚期BC中显著更高.
- CDDN1过度表达在低级高级BC中更为普遍.
- 虽然在统计学上并不显著,但高CDDN1群体的平均总生存期为96个月.
结论:
- CDDN1表达显示出作为晚期乳腺癌的积极预后生物标志物的潜力.
- 需要进一步的研究来充分阐明CDDN1在乳腺癌的预后价值.
相关概念视频
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Molecular Factors Affecting Cell Division
3.1K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


